Safety Issues: Clinical Trials

11 trials for Safety Issues, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Completed 11
Phase 12Completed 2
Phase 32Completed 2

Follow Safety Issues: new trials by email Literature Review of Safety Issues trials Research Report on Safety Issues

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection
15 mg ADC189, 45 mg ADC189, Placebo - Safety Issues, Effect of Drug
Phase 2 / Phase 3CompletedJiaxing AnDiCon Biotech Co.,Ltd7492022-12-072025-01-21
SEPSIS: L. Plantarum Trial
Synbiotic, Probiotic, Placebo - Microbial Colonization, Tolerance
Phase 2CompletedThe Hospital for Sick Children5192022-01-072023-04-13
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
IPG7236 - Safety Issues, Tolerability
Phase 1 / Phase 2CompletedNanjing Immunophage Biotech Co., Ltd342021-11-152026-07-08
ChulaCov19 Vaccine in Healthy Adults
ChulaCov19 vaccine, Placebo - COVID-19 Vaccine, Safety Issues
Phase 1 / Phase 2CompletedChulalongkorn University1922021-05-032023-02-09
Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica
Tofacitinib 5 MG - Polymyalgia Rheumatica, Effect of Drug
Phase 2CompletedRenJi Hospital142021-01-012022-09-15
Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy
Béfizal - Safety Issues, Efficacy, Self
Phase 2 / Phase 3CompletedHôpital Necker-Enfants Malades142019-03-262023-09-22
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants
Vi-DT Vaccine, Vi Polysaccharide Vaccine, IPV Vaccine - Safety Issues, Immunogenicity
Phase 2CompletedPT Bio Farma6002018-07-162020-02-20
Autologous Cord Blood Cells for Prevention of BPD in Preterm
Autologous Umbilical Cord Blood Mononuclear Cells infusion Therapy, 0.9% Sodiun Chloride - Safety Issues, BPD - Bronchopulmonary Dysplasia
Phase 2Completedyangjie622018-07-012020-06-02
Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer
Bevacizumab - Metastatic Triple Negative Breast Cancer, Safety Issues
Phase 2CompletedAssiut University542018-07-012021-03-09
Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population
Quadrivalent Influenza Vaccine, Trivalent Influenza Vaccine - Safety Issues
Phase 2CompletedPT Bio Farma8102017-11-212019-04-02
Remifemin Preventing the Climacteric Symptoms in Breast Cancer
Remifemin - Effect of Drugs, Safety Issues
Phase 2CompletedZhejiang Cancer Hospital852017-01-042018-07-06

Narrower conditions

Breast Neoplasms (1)  ·  Bronchopulmonary Dysplasia (1)  ·  COVID-19 (1)  ·  Communicable Diseases (1)  ·  Perinatal Death (1)  ·  Polymyalgia Rheumatica (1)  ·  Triple Negative Breast Neoplasms (1)

Broader conditions

Skin and Connective Tissue Diseases (3)  ·  Breast Diseases (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Skin Diseases (2)  ·  Breast Neoplasms (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)

Interventions

Bevacizumab (1)  ·  Bezafibrate (1)  ·  ChulaCov19 vaccine (1)  ·  Influenza Vaccines (1)  ·  Prednisone (1)  ·  Probiotics (1)  ·  Remifemin (1)  ·  Synbiotics (1)  ·  Vi polysaccharide vaccine, typhoid (1)  ·  black cohosh root extract (1)  ·  tofacitinib (1)

Sponsors

PT Bio Farma (2)  ·  Assiut University (1)  ·  Chulalongkorn University (1)  ·  Hôpital Necker-Enfants Malades (1)  ·  Jiaxing AnDiCon Biotech Co.,Ltd (1)  ·  Nanjing Immunophage Biotech Co., Ltd (1)  ·  RenJi Hospital (1)  ·  The Hospital for Sick Children (1)  ·  Zhejiang Cancer Hospital (1)  ·  yangjie (1)

Countries

China (5)  ·  Indonesia (2)  ·  Bangladesh (1)  ·  Egypt (1)  ·  France (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Bernie Endyarni, MD (1)  ·  Daniel Roth, MD, PhD (1)  ·  Dominique Bremond Gignac, MD PhD (1)  ·  Jie Yang, PHD (1)  ·  Kiat Ruxrungtham, MD (1)  ·  Meita Dhamayanti (1)  ·  Ting Li, MD (1)  ·  Xingfei Yu (1)

Results publications

PMID 21383283, PMID 22415477, PMID 27501767, PMID 30935866, PMID 31862195, PMID 32004693, PMID 33059607, PMID 34407054, PMID 36604153, PMID 37616221, PMID 38287068, PMID 38297337, PMID 39992135, PMID 40089214, PMID 42066676